Phase II Trial of Docetaxel Therapy in Patients with Advanced Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Phase II Trial of Docetaxel Therapy in Patients with Advanced Hepatocellular Carcinoma

Published:2006 Issue:2 Volume:70 Page:154-158
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Hebbar Mohamed,Ernst Olivier,Cattan Stéphane,Dominguez Sophie,Oprea Corina,Mathurin Philippe,Triboulet Jean-Pierre,Paris Jean-Claude,Pruvot François-René

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference25 articles.

1. Epidemiology of Hepatocellular Carcinoma

2. Systemic therapy for advanced hepatocellular carcinoma: a review

3. Review article: overview of medical treatments in unresectable hepatocellular carcinoma-an impossible meta-analysis?

4. A Phase II study of docetaxel in patients with liver metastases from breast cancer

5. Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycopolymers Mediate Suicide Gene Therapy in ASGPR-Expressing Hepatocellular Carcinoma Cells in Tandem with Docetaxel;Biomacromolecules;2023-02-13

2. Correlation between Immunohistochemical Markers in Hepatocellular Carcinoma Cells and In Vitro High-Throughput Drug Sensitivity Screening;Canadian Journal of Gastroenterology and Hepatology;2022-01-25

3. Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant TP53 or Wild-Type CTNNB1 Gene;Journal of Personalized Medicine;2021-11-13

4. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma;Molecular Pharmaceutics;2020-12-02

5. Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study;AAPS PharmSciTech;2020-06-16